WARREN, R.; CONRAD, C.; FOLEY, P.; IVERSEN, L.; LANGLEY, R.; KOKOLAKIS, G.; DAVIS, L.; VANVOORDEN, V.; WIEGRATZ, S.; MEROLA, J. Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from the BE RADIANT phase 3b trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s70, 2022. DOI: 10.25251/skin.6.supp.70. Disponível em: https://jofskin.org/index.php/skin/article/view/1826. Acesso em: 22 jul. 2024.